Next Century Growth Investors LLC Opti Nose, Inc. Transaction History

Next Century Growth Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$5.84 - $11.92 $1.67 Million - $3.42 Million	-286,513 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$12.43 - $29.76 $126,313 - $302,421	-10,162 Reduced 3.43%	286,513 $3.56 Million
Q2 2018 Aug 14, 2018	BUY	$18.75 - $28.46 $2.63 Million - $3.98 Million	140,019 Added 89.38%	296,675 $8.3 Million
Q1 2018 May 14, 2018	BUY	$15.91 - $20.82 $797,281 - $1.04 Million	50,112 Added 47.03%	156,656 $3.14 Million
Q4 2017 Feb 13, 2018	BUY	$15.2 - $20.76 $1.62 Million - $2.21 Million	106,544	106,544 $2.01 Million

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Next Century Growth Investors LLC with notifications on news.